Jiangsu, China

Xiaoyu Chen

This inventor holds 1 USPTO granted patent. Top assignee: China Pharmaceutical University. Active years: 2025.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Xiaoyu Chen. Retrieved from https://idiyas.com/inventor/xiaoyu-chen-akh4kumf

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Calculating rank

% Patents Active = 100.0

Average Co-Inventor Count = 6.0

ph-index = 1


Company Filing History:


Years Active: 2025

Loading Chart...
1 patent (USPTO):Explore Patents

Title: Innovations of Xiaoyu Chen in Medicinal Chemistry

Introduction

Xiaoyu Chen is a notable inventor in the field of medicinal chemistry, recognized for his contributions to the development of pharmaceutical compounds. His work focuses on addressing significant challenges in drug resistance and efficacy.

Latest Patents

Xiaoyu Chen holds a patent for an innovative compound titled "SHP2 and CDK4/6 dual-target inhibitory compound and pharmaceutical composition containing the same." This invention pertains to the synthesis, preparation method, and application of an inhibitor that targets both SHP2 and CDK4/6. The compound comprises three specific formulas and various acceptable forms, including salts and prodrugs. The invention aims to overcome the limitations of existing inhibitors by providing a novel solution to drug resistance issues.

Career Highlights

Xiaoyu Chen is affiliated with China Pharmaceutical University, where he continues to advance his research in medicinal chemistry. His work has significant implications for the development of new therapeutic strategies.

Collaborations

Xiaoyu Chen collaborates with esteemed colleagues, including Xiaoxing Wu and Wenqiang Li, contributing to a dynamic research environment that fosters innovation.

Conclusion

Xiaoyu Chen's contributions to medicinal chemistry, particularly through his dual-target inhibitor patent, highlight his role in addressing critical challenges in drug development. His work exemplifies the importance of innovation in the pharmaceutical industry.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…